| 000 | 01722 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514005815.0 | ||
| 264 | 0 | _c20020205 | |
| 008 | 200202s 0 0 eng d | ||
| 022 | _a1387-2273 | ||
| 024 | 7 |
_a10.1016/s0378-4347(01)00256-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWerner, U | |
| 245 | 0 | 0 |
_aSelective and rapid liquid chromatography-mass spectrometry method for the quantification of rofecoxib in pharmacokinetic studies with humans. _h[electronic resource] |
| 260 |
_bJournal of chromatography. B, Biomedical sciences and applications _cAug 2001 |
||
| 300 |
_a83-90 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 | _aAtmospheric Pressure |
| 650 | 0 | 4 |
_aChromatography, High Pressure Liquid _xmethods |
| 650 | 0 | 4 | _aCyclooxygenase 2 |
| 650 | 0 | 4 | _aCyclooxygenase 2 Inhibitors |
| 650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoenzymes _xdrug effects |
| 650 | 0 | 4 |
_aLactones _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMass Spectrometry _xmethods |
| 650 | 0 | 4 | _aMembrane Proteins |
| 650 | 0 | 4 |
_aProstaglandin-Endoperoxide Synthases _xdrug effects |
| 650 | 0 | 4 | _aReference Standards |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 | _aSulfones |
| 700 | 1 | _aWerner, D | |
| 700 | 1 | _aMundkowski, R | |
| 700 | 1 | _aGillich, M | |
| 700 | 1 | _aBrune, K | |
| 773 | 0 |
_tJournal of chromatography. B, Biomedical sciences and applications _gvol. 760 _gno. 1 _gp. 83-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0378-4347(01)00256-0 _zAvailable from publisher's website |
| 999 |
_c11446372 _d11446372 |
||